Skip to main content

Table 1 Association of ADRB2 polymorphisms [Arg16Gly (c.46A > G) and Gln27Glu (c.79C > G)] with asthma risk

From: Asthma: Gln27Glu and Arg16Gly polymorphisms of the beta2-adrenergic receptor gene as risk factors

Polymorphism

Genotype

Patient

Control

OR

95% CI

Arg16Gly (c.46A > G) 1,2

Homozygous Arg16

28

9

6.782

3.07-16.03

Heterozygous

38

59

1.056

0.61-1.81

Homozygous Gly16

22

73

0.312

0.17-0.56

 

Total

88

141

  

Gln27Glu(c.79C > G) 3,4

Homozygous Gln27

41

41

2.120

1.22-3.71

Heterozygous

36

11

8.096

3.90-17.77

Homozygous Glu27

11

89

0.084

0.04-0.17

 

Total

88

141

  
  1. ADR2 = alpha2-adrenergic receptor; Arg = arginine; Gly = Glycine; Gln = Glutamine; Glu = Glutamic acid; A = Adenine; G = Guanine; T = Thymine; OR = Odds Ratio; CI = Confidence Interval.
  2. Hardy-Weinberg equilibrium was calculated using the OEGE tool (http://www.oege.org/software/hardy-weinberg.html), being: (1 - patient) χ2 = 1.54, p-value > 0.05; (2 - control) χ2 = 0.48, p-value > 0.05; (3 - patient) χ2 = 0.41, p-value > 0.05; (4 - control) χ2 = 95.62, p-value < 0.001.
  3. The OR was calculated using the Open-Epi tool (http://www.openepi.com). The OR and 95% CI values were obtained using the Mild-P test. For all data analyzed, α = 0.05 was used. The significant p-values are in bold.